Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
324 hedge funds and large institutions have $4.72B invested in Amedisys in 2021 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 111 increasing their positions, 119 reducing their positions, and 79 closing their positions.
40% more call options, than puts
Call options by funds: $38.3M | Put options by funds: $27.3M
13% more capital invested
Capital invested by funds: $4.17B → $4.72B (+$548M)
3.03% more ownership
Funds ownership: 86.72% → 89.76% (+3%)
7% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 119
8% less funds holding
Funds holding: 351 → 324 (-27)
27% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$179M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$92.7M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$91.4M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$62.9M |
| 5 |
JP Morgan Chase
New York
|
+$41.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$56M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$42.6M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$34.9M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$31.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.1M |
AMED Hedge Fund Activity: Q4 2021 in Review
324 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2021, worth a combined $4.72B — up 13% from $4.17B a quarter earlier.
Sellers outnumbered buyers: 79 funds closed out of AMED and 58 opened new positions — a net loss of 21 holders — while 119 trimmed existing stakes and 111 added.
The largest buyer was Wellington Management Group, adding an estimated $179M. The largest seller was AllianceBernstein, cutting an estimated $56M.
- 324 institutional investors held Amedisys (AMED) as of Q4 2021, down from 351 in Q3 2021.
- Funds reported $4.72B of Amedisys stock for Q4 2021, up 13% quarter-over-quarter.
- 58 funds opened new Amedisys positions in Q4 2021 and 79 closed out, a net change of -21 holders.
- The largest Amedisys buyer in Q4 2021 was Wellington Management Group, an estimated $179M added.
- The largest Amedisys seller in Q4 2021 was AllianceBernstein, an estimated $56M sold.
Based on aggregated 13F filings for Q4 2021.